Abstract:7535 Background: The epithelial to mesenchymal transition (EMT) is a fundamental biological process during which epithelial cells change to a mesenchymal phenotype, it has a profound impact on cancer progression and treatment. The purpose of this study was to investigate the role of EMT to predict the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in advanced non-small cell lung cancer (NSCLC) patients. Methods: We evaluated the correlation between EMT and sensitivity to EGFR-TKIs in advanced NSCLC patients. Immunohistochemistry was used to examine the expression of EMT markers, E-cadherin, fibronectin, N-cadherin and vimentin and ARMs was used to detect the EGFR mutation in tumor specimens obtained before the treatment. The EMT phenotype status was determined according to the expression of E-cadherin, fibronectin, N-cadherin and vimentin. Results: 101 patients enrolled into this study and 97 had enough tissue to perform the EMT examination. The median age was 59 years old, male/female:56/45, never smoker/smoker: 71/30, adenocarcinoma/non-adeno: 73/28, PS 0-1/2-3: 83/18, Stage IIIB/IV: 2/99, 1st /2nd-4th line: 13/88. The response rate and progression free survival(PFS) in the whole population were 45.5% and 7.6 months respectively. EMT test revealed that 46(47.4%) samples were epithelial phenotype, while 51(52.6%) were mesenchymal phenotype. 38 of 79 patients harbour activating EGFR mutation. Among the patients with EGFR wild type or unknown status, patients with an epithelial phenotype had a higher response rate(40% Vs 17.6%, P=0.056) and significantly longer PFS(7.6 m Vs 3.8 m, P=0.045) than these with a mesenchymal phenotype. However, the response rate(85.7% Vs 64.7%, P=0.249) and PFS(15.2 m Vs 12.2 m, P=0.420) were similar in the patients with activated EGFR mutation. Conclusions: Patients with an epithelial phenotype got more benefit from the treatment of EGFR-TKIs in the advanced EGFR wild type NSCLC patients, which indicated that the EMT might be a potential marker to guide the individual therapy of EGFR-TKIs in this subpopulation.

ESRP1 As a Prognostic Factor of Non‐small‐cell Lung Cancer is Related to the EMT Transcription Factor of Twist

Expression and clinical significance of ezrin in non--small-cell lung cancer.

Prognostic Value of Twist, Snail and E-cadherin Expression in Pathological N0 Non-Small-cell Lung Cancer: a Retrospective Cohort Study.

Twist, an Independent Prognostic Marker for Predicting Distant Metastasis and Survival Rates of Esophageal Squamous Cell Carcinoma Patients

Association of Epithelial to Mesenchymal Transition with Efficacy of Egfr-Tkis in Non-Small Cell Lung Cancer Patients with Egfr Wild Type

The EMT Transcription Factor, Twist1, As a Novel Therapeutic Target for Pulmonary Sarcomatoid Carcinomas

P3-015: Clinicopathologic Features and Epidermal Growth Factor Receptor Mutations Associated with Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer

Role of epithelial splicing regulatory protein 1 in cancer progression

Nuclear Expression of Twist Promotes Lymphatic Metastasis in Esophageal Squamous Cell Carcinoma

Polymorphisms in Genes Related to Epithelial-Mesenchymal Transition and Risk of Non-Small Cell Lung Cancer

Rac1 Overexpression is Correlated with Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Non-Small Cell Lung Cancer.

Mining Database for the Clinical Significance and Prognostic Value of ESRP1 in Cutaneous Malignant Melanoma.

High levels of MESP1 expression in non-small cell lung cancer can facilitate cell proliferation, metastasis and suppresses cell apoptosis

Data from Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial Cells

Expression of Twist1 in esophageal squamous cell carcinoma tissues and its clinical significance

Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer

Prognostic and Clinicopathological Value of Twist Expression in Esophageal Cancer: A Meta-Analysis

Prognostic value of epithelial-mesenchymal transition-inducing transcription factors in head and neck squamous cell carcinoma: A meta-analysis

Effect of AXL on the Epithelial-to-mesenchymal Transition in Non-Small Cell Lung Cancer

Relationship Between Expression of Twist and KiSS-1 and Progonosis in Non-Small Cell Lung Cancer

P3.03-08 Analysis of ESR1 Mutation Spectrum from Non-Small-Cell Lung Cancer in Chinese Patients